Showing results (641-650 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|October 20, 2010
Microbial contamination of nonsterile pharmaceuticals in public hospital settingsVeronica Mugoyela, Kennedy D MwambeteTherapeutics and Clinical Risk Management|February 12, 2009
A systematic approach of tracking and reporting medication errors at a tertiary care university hospital, Karachi, PakistanKhurshid Khowaja, Rozmin Nizar, Rashida J Merchant, et al.Therapeutics and Clinical Risk Management|February 12, 2009
Risk stratification for arrhythmic death in an emergency department cohort: a new method of nonlinear PD2i analysis of the ECGJames E Skinner, Michael Meyer, William C Dalsey, et al.Therapeutics and Clinical Risk Management|February 12, 2009
Early ischemic CT changes before thrombolysis: The influence of age and diabetes mellitusLars Thomassen, Ulrike Waje-Andreassen, Halvor NaessTherapeutics and Clinical Risk Management|February 12, 2009
Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorderWalter Deberdt, Ilya Lipkovich, Alexandra N Heinloth, et al.Therapeutics and Clinical Risk Management|February 12, 2009
Availability of a remote online hemodynamic monitoring system during treatment in a private dental office for medically high-risk patientsShinya Yamazaki, Hiroyoshi Kawaai, Shigeo Sasaki, et al.Therapeutics and Clinical Risk Management|February 12, 2009
Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysisVincenzo Savica, Domenico Santoro, Paolo Monardo, et al.Therapeutics and Clinical Risk Management|February 12, 2009
Multi-targeted approach in the treatment of thyroid cancerScott N Pinchot, Rebecca S Sippel, Herbert ChenTherapeutics and Clinical Risk Management|February 12, 2009
Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended releaseMary Ann WerzTherapeutics and Clinical Risk Management|February 12, 2009
Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trialsKyoko Taku, Keizo Umegaki, Yoshiko Ishimi, et al.Pageof 256